Central Pharmaceuticals Ltd. (DSE: CENTRALPHL)
Bangladesh
· Delayed Price · Currency is BDT 14.50
-0.40 (-2.68%)
At close: Sep 12, 2024
Central Pharmaceuticals Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Cash & Equivalents | 1.18 | 1.19 | 1.53 | 3.08 | 4.1 | 5.68 | Upgrade
|
| Cash & Short-Term Investments | 1.18 | 1.19 | 1.53 | 3.08 | 4.1 | 5.68 | Upgrade
|
| Cash Growth | - | -22.02% | -50.27% | -24.89% | -27.93% | -14.29% | Upgrade
|
| Receivables | 130.27 | 80.4 | 79.1 | 79.05 | 56.02 | 597.92 | Upgrade
|
| Inventory | 21.1 | 21.6 | 39.7 | 61.4 | 54.06 | 590.72 | Upgrade
|
| Other Current Assets | 296.83 | 287.06 | 286.82 | 287.06 | 280.86 | 282.06 | Upgrade
|
| Total Current Assets | 449.38 | 390.24 | 407.16 | 430.58 | 395.04 | 1,476 | Upgrade
|
| Property, Plant & Equipment | 1,067 | 877.48 | 904.23 | 933.99 | 960.29 | 996.57 | Upgrade
|
| Other Intangible Assets | 0.1 | 0.1 | 0.11 | 0.13 | 0.14 | 0.16 | Upgrade
|
| Other Long-Term Assets | - | 0 | - | 0.13 | - | - | Upgrade
|
| Total Assets | 1,516 | 1,268 | 1,312 | 1,365 | 1,355 | 2,473 | Upgrade
|
| Accounts Payable | 57.29 | 5.29 | 1.5 | 0.65 | 2.04 | 4 | Upgrade
|
| Accrued Expenses | 0.81 | 0.81 | 0.41 | 0.68 | 0.49 | 143.1 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 102.69 | Upgrade
|
| Current Portion of Long-Term Debt | 36.5 | 36.5 | 36.5 | 27.37 | 13.88 | - | Upgrade
|
| Current Income Taxes Payable | 280.81 | 280.2 | 280.02 | 279.87 | 278.98 | 278.98 | Upgrade
|
| Other Current Liabilities | 6.82 | 6.82 | 6.82 | 6.83 | 6.85 | 6.58 | Upgrade
|
| Total Current Liabilities | 382.23 | 329.62 | 325.25 | 315.39 | 302.23 | 535.35 | Upgrade
|
| Long-Term Debt | 250.1 | 231.98 | 231.98 | 224.06 | 212.35 | 102.77 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 33.61 | 36.36 | 40.44 | 43.17 | 50.22 | 53.07 | Upgrade
|
| Other Long-Term Liabilities | - | -0 | - | - | - | -0 | Upgrade
|
| Total Liabilities | 665.94 | 597.95 | 597.67 | 582.62 | 564.79 | 691.19 | Upgrade
|
| Common Stock | 1,198 | 1,198 | 1,198 | 1,198 | 1,198 | 1,198 | Upgrade
|
| Retained Earnings | -1,080 | -1,043 | -999.02 | -930.64 | -922.17 | 69.06 | Upgrade
|
| Comprensive Income & Other | 732.69 | 514.85 | 514.85 | 514.85 | 514.85 | 514.85 | Upgrade
|
| Shareholders' Equity | 850.24 | 669.88 | 713.83 | 782.21 | 790.68 | 1,782 | Upgrade
|
| Total Liabilities & Equity | 1,516 | 1,268 | 1,312 | 1,365 | 1,355 | 2,473 | Upgrade
|
| Total Debt | 286.6 | 268.47 | 268.47 | 251.43 | 226.22 | 205.46 | Upgrade
|
| Net Cash (Debt) | -285.42 | -267.28 | -266.94 | -248.36 | -222.13 | -199.78 | Upgrade
|
| Net Cash Per Share | -2.33 | -2.23 | -2.23 | -2.07 | -1.85 | -1.67 | Upgrade
|
| Filing Date Shares Outstanding | 119.8 | 119.8 | 119.8 | 119.8 | 119.8 | 119.8 | Upgrade
|
| Total Common Shares Outstanding | 119.8 | 119.8 | 119.8 | 119.8 | 119.8 | 119.8 | Upgrade
|
| Working Capital | 67.15 | 60.63 | 81.91 | 115.19 | 92.81 | 941.03 | Upgrade
|
| Book Value Per Share | 7.10 | 5.59 | 5.96 | 6.53 | 6.60 | 14.87 | Upgrade
|
| Tangible Book Value | 850.14 | 669.77 | 713.72 | 782.09 | 790.54 | 1,782 | Upgrade
|
| Tangible Book Value Per Share | 7.10 | 5.59 | 5.96 | 6.53 | 6.60 | 14.87 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.